CSes play a valuable role in bridging the gap between patient care and clinical research but the journey of a CS can be very challenging.

Associate Prof Daniel Ting is a Consultant in the Surgical Retina Department at SNEC, Associate Professor in Ophthalmology with Duke-NUS Medical School, Director of Cluster AI Program at SingHealth, Head of AI and Digital Innovation at SERI and Associate Professor (Courtesy) with NUS Biomedical Engineering. A/Prof Ting is actively involved in the Healthcare AI space at the global setting, serving in several AI executive committee (STARD-AI, DECIDE-AI, American Academy of Ophthalmology) and AI editorial boards (NPJ Digital Medicine, Frontiers in Medicine, and Digital Health). As a clinician scientist, to date, he has published >200 peer-reviewed papers in highly prestigious journals such as JAMA, NEJM, Lancet, Nature Medicine and etc, and recently been ranked the world's most influential deep learning researcher across clinical and technical domains in healthcare for the past 10 years (2010-2021) by the ExpertScape. A/Prof Ting was also recognized by many top-tiered international AI and ophthalmology societies in winning many prestigious scientific awards, including the Asia Pacific Academy of Ophthalmology Nakajima Award (2021), MICCAI OMIA Prestigious Achievement Award (2020), ARVO Bert Glaser Award for Innovative Research in Retina (2020) etc. He was also the visiting Fulbright Scholar to Johns Hopkins University in 2017.